BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
8.91
8.91
년간 변동
6.00
11.31
일일 변동
-1.87%
월간 변동
-1.11%
6달 변화
+25.85%
년간 변동율
-17.88%
이전 종가
9.0 8
Open
8.9 1
저가
8.9 1
High
8.9 1
양
277
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 2.26 B
  • Employee 435
  • Founded 1986
  • CEO Jon P. Stonehouse
  • Website www.biocryst.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLYWX6
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
6.45
주가매출액비율
1.95

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

뉴스